---
input_text: 'Long-Term Organ Function After HCT for SCD: A Report From the Sickle
  Cell Transplant Advocacy and Research Alliance. Hematopoietic cell transplantation
  (HCT) is an established cure for sickle cell disease (SCD) supported by long-term
  survival, but long-term organ function data are lacking. We sought to describe organ
  function and assess predictors for dysfunction in a retrospective cohort (n = 247)
  through the Sickle cell Transplant Advocacy and Research alliance. Patients with
  <1-year follow-up or graft rejection/second HCT were excluded. Organ function data
  were collected from last follow-up. Primary measures were organ function, comparing
  pre- and post-HCT. Bivariable and multivariable analyses were performed for predictors
  of dysfunction. Median age at HCT was 9.4 years; the majority had HbSS (88.2%) and
  severe clinical phenotype (65.4%). Most received matched related (76.9%) bone marrow
  (83.3%) with myeloablative conditioning (MAC; 57.1%). Acute and chronic graft-versus-host
  disease (GVHD) developed in 24.0% and 24.8%. Thirteen patients (5.3%) died >=1 year
  after HCT, primarily from GVHD or infection. More post-HCT patients had low ejection
  or shortening fractions than pre-HCT (0.6%   6.0%, P = .007 and 0%   4.6%, P = .003).
  The proportion with lung disease remained stable. Eight patients (3.2%) had overt
  stroke; most had normal (28.3%) or stable (50.3%) brain magnetic resonance imaging.
  On multivariable analysis, cardiac dysfunction was associated with MAC (odds ratio
  [OR] = 2.71; 95% confidence interval [CI], 1.09-6.77; P = .033) and severe acute
  GVHD (OR = 2.41; 95% CI, 1.04-5.62; P = .041). Neurologic events were associated
  with central nervous system indication (OR = 2.88; 95% CI, 2.00-4.12; P < .001).
  Overall organ dysfunction was associated with age >=16 years (OR = 2.26; 95% CI,
  1.35-3.78; P = .002) and clinically severe disease (OR = 1.64; 95% CI, 1.02-2.63;
  P = .043). In conclusion, our results support consideration of HCT at younger age
  and use of less intense conditioning.'
raw_completion_output: |-
  primary_disease: Sickle cell disease (SCD)

  medical_actions: hematopoietic cell transplantation (HCT); myeloablative conditioning (MAC)

  symptoms: organ dysfunction; cardiac dysfunction; neurologic events; low ejection or shortening fractions; lung disease; overt stroke

  chemicals: 

  action_annotation_relationships: hematopoietic cell transplantation (HCT) TREATS sickle cell disease (SCD); myeloablative conditioning (MAC) CAUSES cardiac dysfunction IN sickle cell disease (SCD); hematopoietic cell transplantation (HCT) PREVENTS organ dysfunction IN sickle cell disease (SCD)
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  hematopoietic cell transplantation (HCT) PREVENTS organ dysfunction IN sickle cell disease (SCD)

  ===

extracted_object:
  primary_disease: MONDO:0007374
  medical_actions:
    - MAXO:0000149
    - myeloablative conditioning (MAC)
  symptoms:
    - organ dysfunction
    - cardiac dysfunction
    - neurologic events
    - low ejection or shortening fractions
    - HP:0002088
    - overt stroke
  action_annotation_relationships:
    - subject: MAXO:0000149
      predicate: TREATS
      object: HP:0007760
    - subject: myeloablative conditioning
      predicate: CAUSES
      object: cardiac dysfunction
      qualifier: MONDO:0011382
      subject_qualifier: MAC
    - subject: MAXO:0000149
      predicate: <PREVENTS>
      object: <organ dysfunction>
      qualifier: MONDO:0007374
      subject_qualifier: <Not Applicable>
      object_qualifier: <Not Applicable>
      subject_extension: <Not Applicable>
      object_extension: <Not Applicable>
named_entities:
  - id: MONDO:0007374
    label: Sickle Cell Disease (SCD)
  - id: MAXO:0000747
    label: Allogeneic hematopoietic stem cell transplantation (HSCT)
  - id: HP:0007760
    label: Sickle Cell Disease (SCD)
  - id: MAXO:0001001
    label: Gene therapy
  - id: CHEBI:28901
    label: Busulfan
  - id: MONDO:0020380
    label: Sickle cell anemia (SCA)
  - id: HP:0001297
    label: Stroke
  - id: CHEBI:44423
    label: Hydroxyurea
  - id: MONDO:0011382
    label: sickle cell anemia
  - id: MAXO:0000149
    label: allogeneic human leukocyte antigen (HLA)-matched sibling and haploidentical
      hematopoietic cell transplant (HCT)
  - id: CHEBI:17303
    label: morphine
  - id: CHEBI:35482
    label: opioid analgesics
  - id: HP:0012532
    label: chronic pain
  - id: CHEBI:6121
    label: ketamine
  - id: HP:0012531
    label: pain
  - id: MAXO:0000748
    label: fecal microbiota transplantation (FMB)
  - id: CHEBI:26666
    label: SCFA
  - id: CHEBI:17968
    label: butyrate
  - id: CHEBI:31011
    label: valerate
  - id: CHEBI:17272
    label: propionate
  - id: MONDO:0005399
    label: Venous thromboembolism (VTE)
  - id: HP:0002140
    label: Ischemic cerebrovascular accidents
  - id: HP:0002098
    label: respiratory distress
  - id: CHEBI:8735
    label: PAINReportIt(R)
  - id: MAXO:0000066
    label: Oxygen supplementation
  - id: MAXO:0000756
    label: Blood transfusions
  - id: HP:0002094
    label: Dyspnea
  - id: CHEBI:33281
    label: antibiotic
  - id: MAXO:0001175
    label: Liver transplantation
  - id: HP:0001395
    label: Liver fibrosis
  - id: MAXO:0000750
    label: conditioning regimen (alemtuzumab, total body irradiation, and sirolimus
      for GVHD prophylaxis)
  - id: CHEBI:9168
    label: sirolimus
  - id: MONDO:0005812
    label: Influenza
  - id: MONDO:0100096
    label: COVID-19
  - id: MONDO:0003847
    label: Genetic diseases
  - id: MONDO:0002492
    label: Acute Kidney Injury (AKI)
  - id: CHEBI:35457
    label: angiotensin-converting enzyme inhibitors
  - id: HP:0001919
    label: AKI
  - id: MONDO:0005300
    label: chronic kidney disease
  - id: HP:0031589
    label: Suicidal ideation
  - id: HP:0000739
    label: anxiety
  - id: MONDO:0005252
    label: heart failure
  - id: MONDO:0005249
    label: pneumonia
  - id: MONDO:0005068
    label: MI
  - id: MONDO:0011751
    label: COPD
  - id: HP:0001907
    label: Thromboembolic events
  - id: HP:0100602
    label: Preeclampsia
  - id: HP:0001511
    label: Fetal growth restriction
  - id: HP:0001622
    label: Preterm birth
  - id: HP:0003826
    label: Stillbirth
  - id: MAXO:0001479
    label: allogeneic hematopoietic stem cell transplantation
  - id: CHEBI:18050
    label: l-glutamine
  - id: HP:0008209
    label: Premature ovarian insufficiency
  - id: HP:0004870
    label: Chronic hemolytic anemia
  - id: CHEBI:17115
    label: Statistical Software Package(s)
  - id: HP:0001903
    label: anemia
  - id: MAXO:0000503
    label: Mechanical ventilation
  - id: MONDO:0010094
    label: sickle cell trait (SCT)
  - id: HP:0000822
    label: hypertension
  - id: HP:0001626
    label: cardiovascular disease
  - id: HP:0000093
    label: proteinuria
  - id: HP:0000083
    label: kidney failure
  - id: HP:0000112
    label: kidney disease
  - id: HP:0001997
    label: Gout
  - id: HP:0002863
    label: myelodysplastic syndrome
  - id: HP:0003418
    label: Back pain
  - id: HP:0002018
    label: Nausea
  - id: HP:0002019
    label: Constipation
  - id: HP:0002014
    label: Diarrhea
  - id: HP:0100785
    label: Insomnia
  - id: CHEBI:50443
    label: hematopoietic stem cells (HSCs)
  - id: HP:0000789
    label: infertility
  - id: CHEBI:41879
    label: dexamethasone
  - id: CHEBI:64360
    label: Tocilizumab
  - id: MONDO:0011549
    label: Hyperhemolysis syndrome (HHS)
  - id: HP:0001896
    label: Reticulocytopenia
  - id: MAXO:0001017
    label: Vaccination
  - id: CHEBI:66919
    label: Ruxolitinib
  - id: CHEBI:76612
    label: Ibrutinib
  - id: MONDO:0013517
    label: beta-thalassemia (beta-TM)
  - id: MONDO:0005047
    label: Infertility
  - id: CHEBI:46195
    label: Acetaminophen
  - id: CHEBI:41423
    label: Celecoxib
  - id: CHEBI:63629
    label: Tizanidine
  - id: CHEBI:6129
    label: Ketorolac
  - id: MONDO:0005290
    label: Rhabdomyolysis
  - id: MAXO:0001121
    label: Kidney biopsy
  - id: MAXO:0000387
    label: Muscle biopsy
  - id: MAXO:0000950
    label: Supportive care
  - id: CHEBI:4027
    label: Cyclophosphamide
  - id: MONDO:0005632
    label: Acute chest syndrome
  - id: CHEBI:16480
    label: nitric oxide
  - id: CHEBI:28304
    label: heparin
  - id: MONDO:0013730
    label: Graft versus host disease (GvHD)
  - id: MAXO:0010030
    label: Bone marrow transplantation
  - id: HP:0002615
    label: Hypotension
  - id: HP:0001662
    label: Bradycardia
  - id: CHEBI:119915
    label: Fentanyl
  - id: MONDO:0006497
    label: Chronic Pancreatitis (CP)
  - id: MAXO:0035049
    label: Endoscopic retrograde cholangiopancreatography
  - id: MAXO:0000004
    label: Surgical procedures
  - id: MAXO:0000088
    label: Dietary interventions
  - id: MONDO:0005003
    label: Chronic Pancreatitis
  - id: CHEBI:17334
    label: penicillin
  - id: HP:0000716
    label: Depression
  - id: MONDO:0001754
    label: Eclampsia
  - id: MONDO:0010088
    label: Musculoskeletal diseases (MSD)
  - id: HP:0034057
    label: congenital defects
  - id: MAXO:0001077
    label: Splenectomy
  - id: HP:0010972
    label: Ineffective erythropoiesis
  - id: MAXO:0000127
    label: genetic testing
  - id: MONDO:0044348
    label: Hemoglobinopathies
  - id: HP:0000026
    label: Testicular failure
  - id: CHEBI:143719
    label: Hib
  - id: CHEBI:143712
    label: menC
  - id: HP:0002090
    label: pneumonia
  - id: HP:0000407
    label: sensorineural hearing loss
  - id: CHEBI:8455
    label: Proguanil
  - id: CHEBI:8673
    label: Pyrimethamine
  - id: MAXO:0009101
    label: Early intervention
  - id: MAXO:0000827
    label: serum ferritin (FER) level measurement
  - id: CHEBI:49005
    label: Deferasirox
  - id: MONDO:0003664
    label: Haemolytic anaemia
  - id: HP:0001923
    label: Reticulocytosis
  - id: HP:0025435
    label: Increased lactate dehydrogenase levels
  - id: HP:0011981
    label: Pigment gallstones
  - id: CHEBI:35341
    label: Steroids
  - id: HP:0001878
    label: Haemolytic anaemia
  - id: HP:0001890
    label: autoimmune haemolytic anaemia
  - id: MAXO:0000021
    label: Palliative care (PC)
  - id: MONDO:0000984
    label: Thalassemia
  - id: MONDO:0004992
    label: Cancer
  - id: HP:0002664
    label: Cancer
  - id: MAXO:0000058
    label: Pharmacological treatment
  - id: HP:0001897
    label: Normocytic anemia
  - id: HP:0000488
    label: Retinopathy
  - id: HP:0010885
    label: Avascular necrosis
  - id: HP:0200023
    label: Priapism
  - id: CHEBI:3216
    label: buprenorphine
  - id: CHEBI:50858
    label: Corticosteroids
  - id: CHEBI:27470
    label: folic acid
  - id: MAXO:0001484
    label: gene editing therapy
  - id: MAXO:0001298
    label: therapy
  - id: HP:0002788
    label: upper respiratory tract infections
  - id: HP:0012735
    label: cough
  - id: HP:0002099
    label: asthma
  - id: MONDO:0004745
    label: Priapism
  - id: HP:0100639
    label: Erectile dysfunction
  - id: CHEBI:33568
    label: Adrenaline
  - id: HP:0001712
    label: Left ventricular hypertrophy
  - id: MAXO:0000139
    label: autopsy
  - id: HP:0033677
    label: Adult Respiratory Distress Syndrome (ARDS)
  - id: HP:0033006
    label: Diffuse Alveolar Damage (DAD)
  - id: MONDO:0018542
    label: Sickle Cell Disease (SCN)
  - id: HP:0001263
    label: Developmental delays
  - id: MONDO:0015194
    label: Sideroblastic anaemia
  - id: HP:0005505
    label: Refractory anaemia
  - id: CHEBI:5588
    label: Hemoglobin A (HbA)
  - id: HP:0007263
    label: <Sickle cell anaemia (SCA)>
  - id: MAXO:0001172
    label: Insulin measurement
  - id: MAXO:0000840
    label: Alanine transaminase (ALT) measurement
  - id: HP:0002910
    label: Abnormal liver function
  - id: CHEBI:145810
    label: Insulin
  - id: CHEBI:37845
    label: Growth hormone (GH)
  - id: CHEBI:137741
    label: Thyroid stimulating hormone (TSH)
  - id: CHEBI:18258
    label: Triiodothyronine (T3)
  - id: CHEBI:18332
    label: Thyroxine (T4)
  - id: CHEBI:37708
    label: Alanine transaminase (ALT)
  - id: MAXO:0000457
    label: pain management
  - id: HP:0012378
    label: Fatigue
  - id: HP:0001945
    label: Fevers
  - id: HP:0002088
    label: lung disease
